Statistical Classification Strategy for Proton Magnetic Resonance Spectra of Soft Tissue Sarcoma: An Exploratory Study with Potential Clinical Utility
暂无分享,去创建一个
Rakesh Patel | Ray L. Somorjai | R. Somorjai | T. Bezabeh | R. Kandel | V. Bramwell | I. Smith | Tedros Bezabeh | Rita Kandel | Ian C. P. Smith | Samy El-Sayed | Vivien Bramwell | Rakesh Patel | S. El‐Sayed
[1] J. Saunders,et al. A simple procedure for obtaining high‐quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies. , 1992, Magnetic resonance in medicine.
[2] L. Seeger,et al. The role of plain radiography, computed tomography, and magnetic resonance imaging in sarcoma evaluation. , 1995, Hematology/oncology clinics of North America.
[3] S. Singer,et al. New diagnostic modalities in soft tissue sarcoma. , 1999, Seminars in surgical oncology.
[4] R L Somorjai,et al. Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.
[5] A. Okada,et al. Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.
[6] D. Cory,et al. Gradient, high‐resolution, magic‐angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue , 1997, Magnetic resonance in medicine.
[7] M. Dewhirst,et al. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. , 1994, Radiology.
[8] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[9] R. Dahiya,et al. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[10] Peter Russell,et al. Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.
[11] C. Mountford,et al. Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.
[12] J. S. Cohen,et al. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.
[13] M. Sivaraja,et al. 1H-NMR detectable fatty acyl chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity. , 1996, The Journal of clinical investigation.
[14] T. Alvegård,et al. Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] T. Brown,et al. Methodological standardization for a multi‐institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies , 2004, NMR in biomedicine.
[16] R L Somorjai,et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.
[17] R. Somorjai,et al. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.
[18] O. Jardetzky,et al. Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR. , 1990, Biochimica et biophysica acta.
[19] W. Negendank. MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995, Magnetic resonance imaging clinics of North America.
[20] Prognostic factors in soft tissue sarcoma. , 1999, Seminars in surgical oncology.
[21] T. Eberlein,et al. Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma , 1994, Annals of surgery.
[22] Negendank Wg. MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995 .
[23] J. Coindre,et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma , 1986, Cancer.
[24] R L Somorjai,et al. Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.
[25] M. Heslin,et al. Imaging of soft tissue sarcomas. , 1999, Surgical oncology clinics of North America.
[26] W. Mackinnon,et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.
[27] R. Somorjai,et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.
[28] R. Pollock,et al. Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.
[29] B Sundell,et al. Soft-tissue sarcomas. , 1979, British medical journal.
[30] R. Lenkinski,et al. Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors , 1991, Cancer.
[31] M. Crowley,et al. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy. , 1989, Radiology.
[32] E. Jackson,et al. Soft-tissue sarcoma of the extremities. MR appearance of post-treatment changes and local recurrences. , 1995, Magnetic Resonance Imaging Clinics of North America.
[33] B. Fletcher,et al. MR imaging of malignant soft-tissue tumors. , 1995, Magnetic resonance imaging clinics of North America.
[34] Hanna Sl,et al. MR imaging of malignant soft-tissue tumors. , 1995 .